| Year |
Citation |
Score |
| 2018 |
Lunter CM, Carroll EL, Housden C, Outtrim J, Forsyth F, Rivera A, Maimaris C, Boyle A, Sahakian BJ, Menon DK, Newcombe VF. Neurocognitive testing in the emergency department: A potential assessment tool for mild traumatic brain injury. Emergency Medicine Australasia : Ema. PMID 30175893 DOI: 10.1111/1742-6723.13163 |
0.385 |
|
| 2017 |
Keong NC, Pena A, Price SJ, Czosnyka M, Czosnyka Z, DeVito EE, Housden CR, Sahakian BJ, Pickard JD. Diffusion tensor imaging profiles reveal specific neural tract distortion in normal pressure hydrocephalus. Plos One. 12: e0181624. PMID 28817574 DOI: 10.1371/journal.pone.0181624 |
0.522 |
|
| 2016 |
Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, et al. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. Human Brain Mapping. PMID 26757216 DOI: 10.1002/Hbm.23087 |
0.449 |
|
| 2015 |
Peterson KA, Housden CR, Killikelly C, DeVito EE, Keong NC, Savulich G, Czosnyka Z, Pickard JD, Sahakian BJ. Apathy, ventriculomegaly and neurocognitive improvement following shunt surgery in normal pressure hydrocephalus. British Journal of Neurosurgery. 1-5. PMID 25968325 DOI: 10.3109/02688697.2015.1029429 |
0.529 |
|
| 2015 |
Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Improving response inhibition in Parkinson's disease with atomoxetine. Biological Psychiatry. 77: 740-8. PMID 24655598 DOI: 10.1016/J.Biopsych.2014.01.024 |
0.428 |
|
| 2014 |
Kehagia AA, Housden CR, Regenthal R, Barker RA, Müller U, Rowe J, Sahakian BJ, Robbins TW. Targeting impulsivity in Parkinson's disease using atomoxetine. Brain : a Journal of Neurology. 137: 1986-97. PMID 24893708 DOI: 10.1093/brain/awu117 |
0.436 |
|
| 2014 |
Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain : a Journal of Neurology. 137: 1145-55. PMID 24578545 DOI: 10.1093/Brain/Awu032 |
0.446 |
|
| 2013 |
Averbeck BB, Djamshidian A, O'Sullivan SS, Housden CR, Roiser JP, Lees AJ. Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease. Behavioral Neuroscience. 127: 245-55. PMID 23565936 DOI: 10.1037/a0032079 |
0.484 |
|
| 2012 |
Sugden C, Housden CR, Aggarwal R, Sahakian BJ, Darzi A. Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: a randomized controlled trial. Annals of Surgery. 255: 222-7. PMID 21997802 DOI: 10.1097/Sla.0B013E3182306C99 |
0.388 |
|
| 2010 |
Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2155-64. PMID 20631686 DOI: 10.1038/npp.2010.84 |
0.47 |
|
| 2010 |
Sugden C, Aggarwal R, Housden C, Sahakian BJ, Darzi A. Pharmacological enhancement of performance in doctors. Bmj (Clinical Research Ed.). 340: c2542. PMID 20483930 DOI: 10.1136/Bmj.C2542 |
0.364 |
|
| Show low-probability matches. |